[go: up one dir, main page]

AU2017904975A0 - Transdermal analgesic formulation - Google Patents

Transdermal analgesic formulation

Info

Publication number
AU2017904975A0
AU2017904975A0 AU2017904975A AU2017904975A AU2017904975A0 AU 2017904975 A0 AU2017904975 A0 AU 2017904975A0 AU 2017904975 A AU2017904975 A AU 2017904975A AU 2017904975 A AU2017904975 A AU 2017904975A AU 2017904975 A0 AU2017904975 A0 AU 2017904975A0
Authority
AU
Australia
Prior art keywords
transdermal analgesic
analgesic formulation
formulation
transdermal
analgesic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017904975A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meat and Livestock Autralia Ltd
Original Assignee
Meat and Livestock Autralia Ltd
Filing date
Publication date
Application filed by Meat and Livestock Autralia Ltd filed Critical Meat and Livestock Autralia Ltd
Publication of AU2017904975A0 publication Critical patent/AU2017904975A0/en
Priority to US16/772,027 priority Critical patent/US12280027B2/en
Priority to ES18887975T priority patent/ES2963687T3/en
Priority to CA3085488A priority patent/CA3085488A1/en
Priority to PCT/AU2018/000255 priority patent/WO2019113625A1/en
Priority to EP18887975.3A priority patent/EP3723729B8/en
Priority to AU2018382217A priority patent/AU2018382217B2/en
Priority to US19/029,515 priority patent/US20250213512A1/en
Abandoned legal-status Critical Current

Links

AU2017904975A 2017-12-11 2017-12-11 Transdermal analgesic formulation Abandoned AU2017904975A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US16/772,027 US12280027B2 (en) 2017-12-11 2018-12-11 Transdermal analgesic formulation
ES18887975T ES2963687T3 (en) 2017-12-11 2018-12-11 Transdermal analgesic formulation
CA3085488A CA3085488A1 (en) 2017-12-11 2018-12-11 Transdermal analgesic formulation
PCT/AU2018/000255 WO2019113625A1 (en) 2017-12-11 2018-12-11 Transdermal analgesic formulation
EP18887975.3A EP3723729B8 (en) 2017-12-11 2018-12-11 Transdermal analgesic formulation
AU2018382217A AU2018382217B2 (en) 2017-12-11 2018-12-11 Transdermal analgesic formulation
US19/029,515 US20250213512A1 (en) 2017-12-11 2025-01-17 Transdermal analgesic formulation

Publications (1)

Publication Number Publication Date
AU2017904975A0 true AU2017904975A0 (en) 2017-12-21

Family

ID=

Similar Documents

Publication Publication Date Title
EP3179856A4 (en) Transdermal cannabinoid formulations
EP3236903A4 (en) Methods and formulations for transdermal administration
EP3204360A4 (en) Therapeutic compounds and uses thereof
EP3174542A4 (en) Transdermal cream
EP3102200A4 (en) Therapeutic compounds and compositions
EP3171859A4 (en) Pharmaceutical composition comprising 5alpha-reductase inhibitor
EP3116489A4 (en) Methods and compositions for transdermal delivery
EP3383370A4 (en) Extended duration local anesthetic formulation
AU2016218074B2 (en) Pharmaceutical formulation
EP3684319A4 (en) Therapeutic device
EP3320945A4 (en) Percutaneous administration device
EP3342423A4 (en) Transdermally absorptive composition
EP3101020A4 (en) Deuterated quinazolinone compound and pharmaceutical composition comprising same
EP3251721A4 (en) Transdermal administration device
EP3326683A4 (en) Percutaneous administration device
EP3095453A4 (en) Topical agent for transdermal administration
EP3265128A4 (en) Oxybutynin transdermal therapeutic system muscarinic agonist combination
EP3384910A4 (en) Transdermal patch
EP3299012A4 (en) Transdermal liquid preparation
EP3150205A4 (en) Transdermal preparation
EP3723729B8 (en) Transdermal analgesic formulation
EP3628043A4 (en) Analgesic compounds
EP3441068A4 (en) Transdermal preparation
AU2017904975A0 (en) Transdermal analgesic formulation
EP3305312A4 (en) External preparation for transdermal administration